gest that T-cell lineage commitment occurs during the transition of CD4'" to pro-T cells. Because it is likely that the thymic microenvironment plays a critical role in T-cell commitment, we compared the responses of CD4" and pro-T cells t o various cytokine combinations in vitro, as well as the ability of the cultured cells t o repopulate organ cultures. Cytokine combinations that maintained T-cell repopulation potential for both CD4'" and pro-T cells were found. CD4" cells proliferated best in response to the combination containing interleukin-l (IL-l), IL-3, IL-6, IL-7, and stem cell factor (SCFI. Unlike CD4" cells, pro-T cells were much more dependent upon IL-7 for proliferation and FTOC repopulation. However, combinations of cytokines lacking IL-7 were found that maintained the T-cell repopulating potential of pro-T cells, suggesting that, whereas this cytokine is clearly very important for normal pro-T cell function, it is not an absolute necessity during early T-cell expansion and differentiation. 0 1995 by The American Society of Hematology.
downregulate CD44 and c-kit expression to become pre-T cells (CD44-CD25' c-kit'" TN), they undergo rearrangements at their TCR p and y TCR loci, implying that pre-T cells are committed to the T-cell lineage. Because these early pre-CD4+ CD8' (double-positive [DP]) thymocyte subsets have only recently been defined, very little is known about their physiology. The effects of thymically derived cytokines on these immature subsets have only begun to be examined." The thymic microenvironment is capable of producing a variety of cytokines, including interleukin-la (IL-la), IL-l@, IL-3, IL-6, IL-7, IL-12, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, granulocyte colony-stimulating factor, and stem cell factor (SCF)." Of these cytokines, the role of IL-7 in T-cell development has been the best defined. Although generation of mature T cells still occurred, in vivo injection of antibodies directed against either IL-7" or IL7RaI3 resulted in a marked decrease in thymic cellularity. These studies suggested an important role for IL-7 in early T-cell proliferation and expansion, but not in differentiation. The stages of T-cell differentiation at which IL-7 exerts its influence are poorly understood. IL-7 has been shown to act as a maintenance factor for immature (CD25+ TN) thymoc y t e~. '~ Godfrey et a19 went on to show that pro-T cells respond to IL-7, whereas later stages of differentiation failed to respond. IL-1 has also been shown to be involved in Tcell differentiation; addition of anti-IL-l antibodies to fetal thymic organ cultures (FTOCs) resulted in inhibition of Tcell maturation." Likewise, IL-6 has been reported to accelerate the differentiation of Thy-l' CD25' TN thymocytes. " We report on the lymphoid lineage commitment status of CD4'" to pro-T cells. CD4'" cells, when intravenously transferred into scid mice recipients, generate both T and B cells. However, pro-T cells only generated T cells when transferred into scid mice. Additionally, FTOCs repopulated with CD4'" cells contain both T and NK cells, whereas repopulation of cultures by pro-T cells results in the generation of T cells almost exclusively. Taken together, these data strongly suggest that commitment to the T-cell lineage oc-curs during the transition to or at the pro-T-cell stage of thymic differentiation. The cytokine responses of CD4'" and pro-T cells also differed significantly. CD4'" cells required combinations of three or more cytokines to proliferate while retaining their ability to repopulate FTOCs. Several cytokine combinations lacking IL-7 (eg, IL-3 plus IL-6 plus SCF and 1L-l plus IL-3 plus IL-6 plus SCF) induced CD4"' proliferation while retaining FTOC repopulation potential. Addition of IL-7 to these combinations resulted in increased cell expansion in vitro and in FTOCs. On the other hand, IL-7 alone was sufficient to maintain FTOC repopulating ability of pro-T cells. Cytokine combinations were found that induced proliferation of CD4'" cells while having little effect on pro-T cells, indicating differential cytokine responsiveness of these cell populations. These data indicate that CD4'" and pro-T cells differ in their ability to generate lymphoid lineage cells and in their response to hematopoietic cytokines, suggesting a role for thymically derived molecules in T-lineage commitment.
MATERIALS AND METHODS
Mice. Four-to five-week-old BALB/c mice (Simonsen Laboratones, Gilroy, CA) were used throughout these experiments unless otherwise noted. For lymphoid repopulation of C.B-I7 scidLscid mice (Simonsen) and NK cell repopulation studies in FTOCs, CD4'" and pro-T cells were sorted from thymi of (C57BL/6 X DBA12)FI (B6D2FI) mice (Simonsen or Jackson Laboratories. Bar Harbor, MA).
Antihodies. All antibodies were purchased from PharMingen (San Diego, CA) unless otherwise specified. For isolation of CD4'" and pro-T cell populations, the following antibodies were used: anti-CD3-biotin (clone 144-2C1 l), anti-CD8-biotin (clone 53-6.7). anti-B220-biotin (clone RA3-6B2). anti-Mac-l-biotin (clone M 1/70). anti-Gr-I -biotin (clone RB6-8CS). anti-NK I . I -biotin (clone PK 136). anti-CD25-fluorescein isothiocyanate (anti-CD25-FITC) (clone 7D4). anti-CD44-phycoerythrin (anti-CD44-PE) (clone IM7). antic-kit-allophycocyanin (clone 2B8), and UltraAvidin-Texas Red (Leinco Technologies, Ballwin, MO). For analyses of in vitro repopulation of fetal lobes and in vivo repopulation of scid recipient mice, the following antibodies were used: anti-CD4-biotin (clone RM4-S ) , anti-CDR-biotin, anti-NKI. I -PE, anti-CD4-Tricolor (clone YTS 191.1 : Caltag Laboratories, South San Francisco. CA). anti-CDR-PE (clone 53-6.7), anti-TCRap-FITC (clone H57-597). anti-TCRyb-FITC (clone GL3). anti-H-2Kh-PE (clone AF6-88.5). rat-anti-mouse IgM-FITC (clone R6-60.2). anti-B220-biotin, and streptavidin-TriColor (Caltag).
Sorting and multiparameter ana/wi.s. The identification and isolation of CD4'" (CD44' CD25-c-kit+ Lin-) and pro-T (CD44' CD25' c-kit+ Lin-) cells has been previously described.'.' Briefly, thymocytes were depleted of CD8' cell by incubation with anti-CD8 (clone AD4; Cedarlane Laboratories, Homby, Ontario) followed by treatment with low-tox M rabbit complement (Cedarlane) and 20 mglmL DNase I (Sigma Chemical CO, St Louis, MO). Viable cells were isolated with Histopaque 1083 (Sigma), then stained as follows: panel of lineage antibodies directed against CD3, CD8, B220, Macl , Gr-l (all biotinylated), anti-CD25-FITC. anti-CD44-PE, and antic-kit-APC. In experiments designed to analyze N K cell regeneration in FTOCs, anti-NKI.l-biotin was added to the lineage cocktail to exclude the possibility of transferring small numbers of contaminating mature NK cells contained within the sorted populations. After washing, cells were incubated with UltraAvidin-Texas Red. CD4'" cells were sorted through a combination Lin-CD2Y and CDUh' c-kithi gate while pro-T cells were sorted through a Lin-CD25' and Sort scheme used for obtaining CD4'" and pro-T cell populations. Thymocytes depleted with anti-CD8 plus C' were stained for expression of CD44, CD25, c-kit, and a panel of lineage antigens as described. To sort CD4'" cells, Lin-CD25-cells were first selected, then CD44 and c-kit expression on these cells was examined. CD44hi c-kithi cells from within the Lin-CD25-population were sorted. Pro-T cells were sorted in a similar fashion, except that the initial sort window was drawn selecting Lin-CD25' cells. From these cells, CD44' c-kithi cells were sorted. CD4'" cells represent -0.02% to 0.05% of total thymocytes, whereas pro-T cells are 5-to 10-fold more abundant.
CD44' c-kit' combination gate (Fig l ) . Cells were sorted using a FACStar Plus or FACS Vantage flow cytometer (Becton Dickinson, San Jose, CA). Sort purities for CD4'" and pro-T cells were routinely greater than 97%.
For analysis of lymphoid repopulation in FTOCs. single cell suspensions were prepared for staining. To reduce nonspecific staining, cells were incubated with anti-FcyRI11111 (clone 2.462) before staining for specific antigen expression. FTOCs were stained with antiTCRaB-FITC or anti-TCRyb-FITC, anti-CD8-PE. and anti-CD4-Tricolor. all in one step. To determine NK cell generation, FTOC cells were stained with both anti-CD4-biotin and anti-CD8-biotin, followed by anti-TCRaB-FITC plus anti-TCRyb-FITC. anti-NKI. I -PE, and streptavidin-Tricolor. Cells were gated on the CD4-8-population, then analyzed for TCR and NKI.1 expression. It is important to note that the host fetal lobes are from BALB/c mice that are negative for the NK I . I marker. Therefore, all NK I. I staining must be derived from donor B6D2FI sorted CD4'" or pro-T cells.
Lymphoid repopulation in scid recipients was examined as follows: Donor cells were detected by staining with an anti-H-2Kh antibody previously titered such that all control H-2Kh-positive thymocytes were stained. Donor thymic repopulation was determined by staining cells with anti-H-2Kh-PE, anti-CD8-FITC, and anti-CD4-Tricolor. R-cell repopulation in spleen and BM was determined by staining with anti-H-2Kh-PE. rat-antimouse IgM-FITC, and anti-B220-biotin followed by streptavidin-Tricolor. Donor (H-2K'"positive) cells were gated and then analyzed for expression of B220 and IgM. Stained cells were collected using a FACScan cytometer (Becton Dickinson) using Lysis 11 software, whereas data analysis was performed using CellQuest software (Becton Dickinson).
In vivo repopulntion qf C.B-17 scid mice. C.R-I7 scirlLscid (H- recipients . As a positive control for T-cell repopulation, one group of mice was injected with BM cells. On day 26, mice were killed, thymi were excised, and cellularities were determined. Cells were then phenotyped for donor repopulation (H-2Kb-positive cells) as well as for the expression of CD4 and CD8. Data presented as the mean (SEM) of three to four independent experiments, each consisting of two to four mice per experimental group. zd) mice were exposed to 300 cGy 4 to S hours before cell transfer to facilitate lymphocyte engraftment.I7 CD4'" and pro-T thymocytes were sorted from B6D2F1 (H-2b'd) mice as described, then injected (3.1 to 4.8 X lo4 CD4'" cells/mouse, 4.7 to 9.2 X IO4 pro-T cells/ mouse) into the lateral tail vein of recipients. As a positive control for T-and B-cell repopulation, one group of mice received 1 X 10' whole BM cells from B6D2F1 mice. Mice were killed on day 26 post-cell transfer, and then single cell suspensions of thymus, spleen, and BM cells were examined for repopulation as described above. Donor-derived cells were determined by staining for expression of H-2Kb. Data presented in Tables 1 and 2 are from three to four independent experiments, each consisting of two to four mice per experimental group.
In vitro culture. Sorted thymic populations were cultured in medium consisting of RPM1 1640 containing 10% fetal calf serum
nol, minimal essential medium amino acids and vitamins, sodium bicarbonate, penicillin, streptomycin, and gentamycin. To this complete medium, the following cytokines were added in various combinations: IL-la (0.2 ng/mL; R&D Systems, Minneapolis, MN), IL-3 (3% Silkworm preparation; DNAX, Palo Alto, CA), IL-6 (200 U/ mL; DNAX), IL-7 (0.5 ng/mL; PeproTech Inc. Rocky Hill, NJ), IL-12 (1,000 U/mL; M. Gately, Hoffman-LaRoche, Nutley, NJ), and SCF (50 U/mL, DNAX). Cytokine concentrations were determined before usage. For FTOCs, complete medium containing 20% FCS was used. Both CD4'" and pro-T cells were absolutely dependent upon the addition of exogenous cytokines, the culture of either cell population in complete medium alone for 3 days did not yield any viable cells (data not shown).
Sorted CD4'" and pro-T cells were incubated in round-bottom 96-well plates (Coming, Coming, NY) in 200 pL complete medium containing various cytokine combinations. Cells were cultured at a concentration of 2 to 4 X lo4 cells/well. After 3 days, cells were procured and viable cell counts determined by trypan blue exclusion. Cells were then used for FTOC repopulation studies.
FTOC. Fetal thymic lobes were removed at day 15 gestation and depleted of endogenous T-cell progenitors by culturing in FTOC medium containing 1.35 mmol/L deoxyguanosine for S days as described.'* Depleted lobes were then individually plated with l X 10' cells in 30 pL volume in Terasaki plates (Nunc, Kamstrup, Denmark). Plates were then inverted to allow lobe and cells to combine at the bottom of a hanging drop." After 24 to 48 hours, recolonized lobes were transferred back into FTOC for 21 to 24 days, being refed with FTOC medium every 6 days. At the indicated time points.
lobes were gently pressed under a glass coverslip in 100 pL phosphate-buffered saline containing 2% FCS to release thymocytes. Thymocytes were then phenotyped as described above. Sorted CD4'" and pro-T cells from B6D2F1 (H-2b/d) donors were intravenously injected into 300R irradiated C.B-17 scid (H-2d) recipients. A S a positive control for B-cell repopulation, one group of mice was injected with BM cells. On day 26, mice were killed and lymphoid repopulation was examined. Thymic repopulation was detailed in Table 1 . Single cell suspensions of BM and spleen cells were prepared and stained for expression of H-2Kb, 8220, and slgM. The percent donor cell repopulation was determined by gating on all nucleated cells. To determine donorderived 8220' slgM' and B220+ slg" cells, BM and spleen cells were gated on lymphocyte-sized cells expressing H-2Kb and then analyzed for B220 and slgM expression. Data presented a s the mean (SEM) of three to four independent experiments, each consisting of two to four mice per experimental group.
RESULTS

Lineage
* Expression of B220 and slgM on irradiated scid BM cells and spleen cells is based on endogenous host scid cell expression.
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From and pro-T (CD44+ C D 2 9 c-kit') cells contain germline p and y TCR l~c i ,~,~ whereas pre-T (CD44 CD25+ c-kit'") cells have already undergone TCR p and y gene rearrangement: These data suggest that commitment to the Tcell lineage occurs before TCR rearrangements in pre-T cells. If this is the case, two possibilities exist: commitment occurs as CM'' cells differentiate into pro-T cells, or commitment occurs as pro-T cells differentiate into pre-T cells, but before TCR rearrangement. To examine these possibilities, we sought to determine whether both CD4l" and pro-T cells have the capacity to generate lymphoid lineage cells.
CD4'" and pro-T cells were sorted from B6D2F1 mice and intravenously injected into lightly irradiated C.B-17 scid recipients. Twenty-six days posttransfer, mice were killed and the T-and B-cell repopulation of thymus, spleen, and BM was examined. Both CD4'" and pro-T cells repopulated the thymus of scid recipients with donor-derived T cells (Table 1) . We observed a virtual absence of immature CD4-CD8-(DN) donor cells, a consequence of a single wave of repopulation caused by the lack of self-renewal capacity of the donor cells. CD4" recipients had a higher percentage of immature DP cells as compared with recipients of pro-T cells. This is predictable because pro-T cells are further along the T-cell differentiation pathway and, therefore, would be expected to display more rapid repopulation kinetics than CD4'" cells! The majority of donor origin cells within the thymi of pro-T and CD4' O repopulated mice were mature (TCRh') single-positive CD4 or CD8 cells (data not shown). Further evidence that pro-T cells are more differentiated was seen in the thymic cellularities of repopulated scid mice. Scid recipients of CD4'" cells contained many more thymus cells than did recipients of pro-T cells (= 11 X 106 cells v -2 X lo6; Table l), indicating an increased proliferative potential for CD4'" cells as compared to pro-T cells. Although we should point out that these cells never express TCR, there were variable numbers of CD4 and/or CD8 expressing host cells, in agreement with earlier reports that have shown that irradiation of scid mice induces expression of CD4 and CD8?'.'' Both CD4'" and pro-T cells displayed poor BM repopulating ability, with only approximately 5% of total BM cells being of donor origin (Table 2 ). This was expected because both cell populations were devoid of pluripotent stem cells that exhibit high BM repopulating ability.zz~23 To determine B-cell repopulation, we examined the expression of B220 and IgM on donor-derived cells. As shown in Fig 2, recipients of CD4'" thymocytes had donor B220+ IgM+ and B220+ IgM-cells in their BM and spleen. However, the majority of donor cells lacked B220 and were Thy-1.2 expressing T cells (data not shown). Interestingly, when pro-T-cell recipients were examined for B-cell repopulation in BM and spleen, no B220' donor cells were observed (Fig 2) . All donor cells found in the spleen and BM of pro-T-cell recipients were T cells (data not shown). We were unable to consistently detect any donor-derived NK cells in any of the scid recipients, regardless of the cell population transferred. This was most likely caused by the normally low frequency with which NK cells are found in peripheral organs.
Because it has been reported that CD4'" cells retain the capacity to generate NK cells as well as B cells' and we were unable to detect any NK cell repopulation using our scid-adoptive transfer protocol, we chose to examine NK cell repopulation potential using R O C . We repopulated BALBk fetal lobes with CD4'" or pro-T cells sorted from B6D2F1 donor mice and examined T and NK cell repopulation 21 days later. Because BALBk mice lack expression of NK1.1, any cells expressing this marker are, by default, of donor origin. As can be seen in Fig 3, NK cells are present at very low numbers within an adult thymus (= 1% of DN cells, which themselves comprise -2% of total thymocytes). FTOCs repopulated with CD4'" cells clearly contain a population of DN NK1 .l+ TCR-cells (Fig 3) .
Taken together, these data strongly suggest that commitment to the T-cell lineage occurs either during the transition from CD4'" to pro-T cells or very rapidly after arrival of cells into the pro-T cell pool. The ability to generate NK cells appears to be lost after the ability to generate B cells, suggesting a sequential loss of lymphoid lineage potential during thymocyte differentiation.
Cytokine responses of CD4'" and pro-T cells. Data presented thus far indicates that T-cell lineage commitment of early thymic progenitors occurs during the transition from CD4" to pro-T cells. The most likely explanation for this commitment is the induction of multipotent CD4'" cells toward the T-cell lineage by the thymic microenvironment. Consequently, the cytokine responsiveness of multipotent CD4l" cells may vary from that of pro-T cells.
Previously, we have shown that IL-7 served as a maintenance factor for CD25+ TN thymocyte^.'^ L 7 did not induce proliferation of these cells, but rather maintained their viability in culture for up to 7 days. Moreover, these IL-7-cultured TN cells maintained their T progenitor activity as measured by their ability to repopulate FTOCs. Further examination indicated that this effect of IL-7 was restricted to CD44+ CD25+ pro-T cells! As was seen with CD25+ TN cells, IL-7 cultured pro-T cells retained their FTOC repopulating ability. Additionally, culture of pro-T cells in IL-7 plus SCF resulted in cell expansion and retention of T progenitor a c t i~i t y .~ Taken together, these results strongly suggest a dependence of IL-7 by pro-T cells and that IL-7 alone is sufficient for the maintenance of T-cell progenitor potential.
Because it is likely that cytokine interactions play a crucial role in the commitment to the T-cell lineage, we investigated the cytokine responsiveness of CD4" and pro-T cells. First, we examined the response of CD4" cells to IL-7 with or without SCF. Sorted CD4'" and pro-T cells were cultured in IL-7 or IL-7 plus SCF for 3 days. As previously reported, IL-7 with or without SCF maintained the viability and FTOC repopulating potential of pro-T cells. In sharp contrast, neither IL-7 nor IL-7 plus SCF Representative phenotypic analysis of B-cell repopulation in scid recipients of CD4" or pro-T cells. BM and spleen B-cell repopulation was analyzed 26 days after injection with sorted cells. To determine donor-derived 8220' slgM' and 8220' slg" cells, BM and spleen cells were gated on lymphocyte-sized cells expressing H-2Kb, then analyzed for B220 and slgM expression. Mice injected with CD4" cells clearly contain donor-derived 6220' slgM' and 8220' slg" cells (first column). In contrast, pro-T-cell repopulated scid mice are devoid of any donor B cells, displaying identical staining patterns as irradiated scid mice negative controls (second and third columns). Mice injected with BM cells were used as a positive control for B-cell repopulation (see Table 2 for summary of B-cell repopulationl.
significantly supported viability of CD4'" cells (Fig 4). We that either IL-7 is not required for CD4'" maintenance, or then asked whether the cells surviving in vitro culture that CD4'" cells require a broader spectrum of cytokines retained their ability to generate mature T cells. To address in addition to IL-7 and SCF. this. we used FTOC to assess the T-cell regeneration po-
Because it has been well documented that multipotent tential of these cells. Interestingly, the surviving CD4'" hematopoietic progenitor and stem cells proliferate in recells were unable to repopulate FTOC. These data suggest sponse to a combination of several cytokines, whereas lin- For personal use only. on October 31, 2017. by guest www.bloodjournal.org From eage commitment appears to decrease the required number of cytokines needed to induce proliferation," we expanded the search for cytokine combinations capable of maintenance/expansion of multipotent CD4'" cells while still retaining their ability to generate T cells in FTOCs. Working on the assumption that CD4'" cells are more "stem cell like" than committed pro-T cells, we examined the effect of several cytokines that have been shown to have an effect on BM hematopoietic stem and progenitor cells (summarized in Fig 4) . IL-3 plus SCF maintained the viability of CD4'" cells: however. these cells failed to repopulate FTOCs. The addition of IL-7 to IL-3 plus SCF resulted in the ability of these CD4'" cells to repopdate FTOC. This would suggest a requirement for IL-7 in the maintenance of T progenitor potential along with the necessity of other cytokines to induce survival and/or proliferation. Culture of CD4'" cells in IL-3 plus IL-6 plus SCF resulted in ;I slight expansion in cell numbers and addition of IL-7 to this combination resulted in slightly increascd cell recovery. Interestingly. CD4'" cells cultured in IL-3 plus IL-6 plus SCF or IL-3 plus IL-6 plus IL-7 plus SCF repopulated FTOC (Figs 4 and S) . However. addition of IL-7 resulted in an approximately fourfold greater cell expansion in FTOC. This effect of IL-7 on cell expansion could be further seen when CD4'" cells were cultured in cytokine combinations containing IL-la. Addition of IL-7 to IL-l plus IL-3 plus IL-6 plus SCF produced both an increase in in vitro proliferation and a twofold increase in cell expansion in FTOCs. Surprisingly. the cells recovered from lobes repopulated with IL-l plus IL-3 plus IL-6 plus SCF-cultured CD4'" cells were largely CD4 ~ CD8 , whereas addition of IL-7 appeared to promote differentiation (Fig S) . 1855 Similarly. addition of IL-7 to IL-l plus IL-3 plus SCF resulted in enhanced differentiation. I t is also interesting to note that the addition of 1L-7 to various cytokine combinations during the initial 3 days of culture enhances the ability of the cultured CD4'" cells to generate DN TCRyb + T cells (Fig S) . These findings are in agreement with others indicating a role for IL-7 in y b T-cell differentiation and expansion.".'" Thus. CD4'" thymocytes resemble BM multilineage progenitor and stem cells in their requirement for multiple cytokines to induce proliferation. We have identified cytokine combinations lacking IL-7 that resulted in both in vitro proliferation and retention of T-repopulating ability of CD4'" cells (Figs 4, S) . The addition of IL-7 to these cultures resulted in increased proliferation and T-cell expansion in FTOCs. indicating an important but not absolute role for IL-7 in the expansion/differentiation of the most immature thymic cell population.
ADULT THYMUS CD41°FTOC (CD4-8-gated cells) (CD4-8-gated cells)
PRO-T FTOC
Having shown in detail the responsiveness of CD4'" cells to multiple cytokines, we wished to examine the cytokine response protile of pro-T cells. The addition of IL-3, IL-6. or IL-12 to pro-T cells cultured in IL-7 plus SCF showed no significant additional effect on cell recovery after 3 days in culture (Fig 4) . These culture conditions also retained FTOC repopulation potential (Fig 4. data not shown) . The addition of four or more cytokines (IL-3 plus IL-7 plus 1L-SCF) induced significant cell expansion while maintaining the ability to repopulate FTOCs. In sharp contrast to CD4'" cells, pro-T cells failed to respond significantly to any cytokine combination lacking IL-7. indicating clear differences in cytokine responsiveness between these two cell popula-
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( o v n l tions. However, it is important to note that pro-T cells cultured in IL-l plus IL-3 plus IL-6 plus SCF or IL-3 plus IL-6 plus SCF, although having relatively poor cell yields after 3 days of culture, were still able to repopulate R O C (Fig  6) , albeit with much lower FTOC cell yields. These data highlight the increased dependence of pro-T cells on IL-7 as compared with the more immature CD4'" cell population.
DISCUSSION
Commitment of the earliest thymic progenitors to the Tcell lineage is a poorly understood process. Although it has been shown that CD4'" cells found in the thymus have the capacity to generate T. B. NK. and dendritic cells when transferred into recipient it is not known if subsequent stages of thymic differentiation retain this property.
Nor is it known which cytokines may be involved in the expansion of these early thymic progenitor populations. Until recently, studies addressing these issues have proven difficult to perform because of the complexity of intrathymic differentiation. The precise phenotypic delineation of the earliest steps of intrathymic maturation occtlrring before For TCR p rearrangement and expression of CD4 and CD8 has allowed us to address the issues of T-lineage commitment and cytokine responses of early thymic progenitors. ' Our results from intravenous injection of sorted CD4'" and pro-T cells strongly suggest that, unlike CD4'" cells, pro-T cells have lost the ability to generate B cells in recipient mice. To our knowledge, this is the first analysis of the repopulation potential of pro-T cells in vivo. This result was not entirely unexpected. We have previously reported that although pro-T cells have their TCR loci in germline configuration, they transcribe two TCR-0 chain germline mRNAs of 1 .O and 1.6 kb.j The presence of these transcripts indicates that the TCR-P chain gene locus chromatin has already opened in pro-T cells, as would be expected of cells committed to differentiation along the T-cell pathway. As pro-T cells downregulate c-kit and CD44, they undergo TCR-0 and -y chain loci rearrangement to become pre-T cells (Fig  7) .' These characteristics strongly suggest that pro-T cells are the targets for the signals that induce TCR gene rearrangement. Furthermore, pro-T cells are capable of significant cytokine production (including IL-2 and interferony ) when activated with calcium ionophore, phorbol ester and IL-I ." In fact, we recently cloned a new cytokine (designated lymphotactin) from an activated pro-T-cell cDNA library." Lymphotactin is an abundant T-cell-specific cytokine produced by various subsets of mature T cells." Taken together. these observations indicate that pro-T cells already exhibit a number of T-cell-like characteristics.
Several observations can be made from our data detailing the repopulation of scid recipients with CD4'" or pro-T cells. It has been shown that CD4'" thymocytes do not generate B cells when intrathymically transferred into recipient mice. B-cell generation was observed only when the cells were injected intravenously.5 After this protocol, we confirmed the ability of CD4'" cells to generate B cells. We also report for the first time that pro-T cells have lost the ability to differentiate into B cells upon intravenous transfer into scid mice. However. the possibility exists that upon intravenous transfer, pro-T cells specifically home to the thymus, having lost the ability to home back to the BM." It is possible that if pro-T cells were placed in a B-lymphopoietic environment, generation of B cells may occur. We are currently investigating this possibility using in vitro culture conditions favoring B-cell differentiation. The majority of donor cells found in the BM and spleen of CD4'" recipients are T cells. B-cell generation occurs at a very low frequency, unlike that seen when mice are repopulated with BM cells (Fig 2) . This suggests that either CD4'" cells are already biased toward the T-cell lineage or that the B-cell expansion potential is significantly less than that of T cells. We also consistently observed fewer host-derived DP thymocytes in pro-T-cell scid recipients as compared with recipients of either CD4'" or BM cells (Table l ) . We have no clear explanation for this observation. One possibility is that transferred pro-T cells, known to produce a variety of cytokines, interact with the host thymus in such a way as to inhibit the generation of host scid DP cells.
We were unable to detect donor NK cell generation in scid recipients, even those injected with whole BM cells. This is most likely because of the paucity of NK cells normally found in hematopoietic tissues. This necessitated the use of FTOCs to determine the ability of CD4'" and pro-T cells to generate NK cells. As can be seen in Fig 3, CD4' " cells retain the ability to generate intrathymic NK cells. Interestingly, although highly skewed towards T-cell production, pro-T cells also appear to retain a very limited capacity to generate NK cells (approximately 5-to IO-fold fewer NK cells produced as compared with CD4" cells). Together, these data suggest a sequential loss of B and NK cell potential during thymic maturation. The delayed loss of NK cell repopulating potential is not overly surprising in light of the many shared characteristics of T and NK cells. It is quite likely that this would extend to shared microenvironmental signals during development of both cell lineages. Altematively, there may be separate phenotypically indistinguishable subpopulations within pro-T cells capable of differentiating into T cells and NK cells. Further studies are needed to address these possibilities.
These observations also imply that the signals which induce CD4'" precursors to become T-cell lineage committed pro-T cells must exist in the thymic microenvironment. Cytokines are likely candidates to be involved in this process. Accordingly. we compared the responses to cytokines of CD4'" and pro-T cells. The results of these experiments provide further evidence of the stem cell-like nature of CD4'" thymic precursors. CD4'" cells proliferated best in multiple cytokine combinations containing IL-I, IL-3, IL-6, IL-7, and SCF. This is reminiscent of responses of cells with similar phenotype and stem cell potential found in the BM.24 A cytokine of particular importance in this analysis is IL-7, because it is a likely candidate for being a lymphoid-promoting growth and differentiation factor. Overall, IL-7 was not For personal use only. on October 31, 2017. by guest www.bloodjournal.org From necessary for significant proliferation of CD4'" progenitors in vitro or for retention of R O C repopulation capacity; however, the cell yields both in vitro and in vivo (floc) were higher when IL-7 was included. In contrast with CD4'" cells, pro-T cells were markedly more dependent upon the presence of IL-7. IL-7 alone or with SCF maintained the ability of pro-T cells to repopulate FTOCs. Furthermore, the addition of IL-7 to other cytokine combinations always improved the cell yields both in vivo and in vitro. Overall, the presence of IL-7 during culture of pro-T cells in vitro promoted the maintenance of their T-cell repopulation potential in FTOC (eg, pro-T cells cultured in IL-I2 plus SCF or IL-3 plus SCF with or without IL-7; Fig 4) . These observations confirm and extend our previous conclusions"'.'" indicating that pro-T cells are likely a key target for IL-7 during early T-cell development. This model would be in agreement with a putative role for IL-7 in the maintenance of lymphoidcommitted progenitors. Importantly, we also identified at least one cytokine combination that did not involve IL-7 (IL-1 plus IL-3 plus IL-6 plus SCF) that allowed pro-T cells to retain their ITOC repopulating ability. The latter result suggests that, whereas IL-7 may greatly augment the proliferative capacity of pro-T cells, it is not an absolute requirement during early T-cell development.
These data are consistent with earlier in vivo studies focusing on the potential role of IL-7 in T-cell development. Mice injected with anti-IL-7 antibody have greatly decreased thymic cellularities, but they still have relatively normal CD4/CD8 ratios and functional peripheral T cells." Likewise, injection of anti-IL-7R antibody capable of blocking the binding of IL-7 to its receptor resulted in decreased thymic cellularity, but not a complete blockage of T-cell development.I3 These studies suggested an important but not absolute requirement for IL-7 in proliferation and expansion of early thymic populations. It is possible that cytokines other than IL-7 could drive early thymic progenitors to expand and differentiate at a low level. Our in vitro culture data supports this conclusion. Further support for this concept comes from the recent generation of several cytokine or cytokine receptor knockout mouse models by homologous recombination. An IL-7-deficient mouse has been generated; these mice, although having drastically decreased thymic cellularities, contain both normal CD4' and CD8' ratios and mature CD4' or CD8' cells in the thymus and periphery.'" An essentially identical phenotype was observed when the IL-2Ry chain was deleted." Although the IL-2Ry chain is used to form the IL-7R it is also used to form other cytokine receptors,'"'(' making it difficult to analyze the actual contribution of IL-7 to the phenotype of these mice. Likewise, an IL-7Ra chain knockout mouse has been recently d e~c r i b e d .~~ These mice display variable effects on thymocyte development, ranging from that seen in IL-7 and IL-2Ry knockout mice to a complete block at the CD4'" stage. The recent discovery of a new IL-7-like cytokine termed "thymic stromal-derived lymphopoietin," whose receptor uses the IL-7Ra chain, is the most likely factor involved in the apparent differences between the IL-7 and IL7Ra knockout Muegge et al" observed that fetal thymocytes cultured with IL-7 in vitro rearrange their TCR-0 chain locus, and suggested a role for IL-7 in the induction of TCR rearrangement. However, our data are more consistent with a role for IL-7 as a physiologic survival factor for these cells, which may have already received the signals to rearrange TCR-0 chain genes in vivo. This is a much more likely explanation because these investigators used unseparated day 14 fetal thymocytes, some of which have probably already begun D-J rearrangements of the TCR-0 chain locus, unlike purified pro-T cells. In fact, we have observed that pro-T cells cultured with IL-7 f SCF do not rearrange their TCR-0 chain locus (J. Kennedy and A. Zlotnik, unpublished observation, September 1993).
It is also worth noting that both CD4'" and pro-T cells, when cultured in cytokine combinations differing only by the presence of IL-7, display increased TCRyS T-cell repopulation of ITOCs when cultured with IL-7 before FTOC seeding ( Figs 5 and 6 ). These data are in agreement with previous reports indicating that IL-7 appeared to promote the expansion of y b T cells.'5~'" Although these studies are the first to rigorously examine the cytokine responsiveness of intrathymic progenitors, others have examined the response of BM-derived thymic progenitors. Chervenak et al have reported the expansion of pre-T-cell activity when CD3-Thy-1.2' BM cells were cultured in 1L-3 plus SCF.") This pre-T activity was measured by thymic repopulation after intrathymic injection. However, expansion of other lineage progenitor cells was not examined; it is likely that IL-3 plus SCF maintained multilineage stem andor progenitor cells that have been shown to be able to repopulate thymic lobes when intrathymically transfe~~ed.''.~' More recently, another study tried to compare BM and thymic CD4'" progenitor^.^' Unfortunately, the latter study is flawed because of the procedure used to purify CD4'" thymic progenitors. Their protocol would result in major contamination with CD4'" CD3 CD8-CD44 c-kitthymocytes, which represent a much more mature stage of direct precursors of DP thymocytes.'" This suspicion was confirmed by the authors themselves when they reported that only = 1% of their CD8-CD3-CD4'" cells expressed c-kit, unlike CD4'" progenitors, which are all c-kit' .4.7 Thymic stem cells from fetal liver have been recently examined for their cytokine responsiveness. McKenna et aI4' report that fetal liver cells cultured in IL-10, IL-3, IL-6, or leukemia inhibitory factor with or without SCF for up to 7 days retained their ability to repopulate thymic lobes upon intrathymic injection. Interestingly, culture in IL-7 plus SCF failed to maintain thymic repopulating ability. This is in agreement with our studies indicating that the T-cell repopulating potential of the earliest thymic CD4'" progenitors is not maintained by IL-7 plus SCF. Most likely, progenitor cells from either BM or fetal liver, which seed the thymus, have a cytokine response pattern similar to that of CD4'" thymic progenitors described here. A BM-derived cell population likely to seed the thymus has been recently described." It would be of interest to compare the cytokine responses of these BM-derived cells to thymic CD4'" cells.
Although we have described various culture conditions capable of supporting survival and growth of CD4'" cells, For personal use only. on October 31, 2017. by guest www.bloodjournal.org From we have not yet examined the effects of these conditions on lineage commitment. We have defined cytokine combinations with or without E -7 that maintain T-cell progenitor activity as determined by FTOC repopulation. We are currently determining whether CD4'" cells cultured under these conditions (eg, IL-3 plus IL-6 plus SCF and IL-1 plus IL-3 plus IL-6 plus SCF with or without IL-7) are still able to generate B cells in vivo or in vitro. One possibility is that exposure to IL-7 may induce commitment to the T-cell lineage. Preliminary studies have shown that CD4'" cells cultured under these conditions for 6 to 8 days maintain their phenotype (CD44+ CD2Y c-kit+), suggesting that CD4'" cells have not been induced to differentiate into pro-T cells (data not shown). We are also attempting to determine the clonal response of CD4'" cells to these various culture conditions in an attempt to determine the potential heterogeneity of this population. Future experiments will aim to clarify these issues.
